Diabetes is a pervasive chronic disease with significant economic repercussions globally. This article examines the economic impact of diabetes, focusing on direct and indirect costs as well as broader societal implications. Direct costs include healthcare expenditures such as medical treatment, hospitalizations, medications, and professional care. Indirect costs encompass lost productivity due to absenteeism and presenteeism, disability, premature mortality, and the burden on informal caregivers. The strain on healthcare systems and the exacerbation of economic inequality are highlighted as broader societal consequences. The article underscores the necessity of comprehensive prevention, management, and policy interventions to mitigate the economic burden of diabetes and improve health outcomes.
